Scott Byrd is the founder of Sudo Biosciences. Sudo Biosciences has raised $188M in total funding. Latest round: Series B. Based in Carmel, IN, USA.
Scott Byrd is the Chief Executive Officer of Sudo Biosciences, a biopharmaceutical company focused on developing precision TYK2 inhibitors for autoimmune and neurologic conditions. Under his leadership, Sudo Biosciences has raised a total of $188 million since its founding in 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library